Osmotica Pharmaceutical Corp. (Biotechnology, Pharmaceutical) — Funding, Investors & Signals 2026

Osmotica Pharmaceutical Corp.

Founded 2000

Bridgewater, United States 114 employees Post Ipo Debt Total: $169.50M Biotechnology, Pharmaceutical

Osmotica Pharmaceutical Corp. is a fully-integrated pharmaceutical company with expertise in developing commercially successful products. As one of the world's leading osmotic drug delivery companies, they leverage significant resources in R&D and proprietary drug delivery technology to address the growing need of the global patient population. The company has the resources and experience to successfully commercialize their products through their subsidiaries, Vertical Pharmaceuticals, LLC and Trigen Laboratories, LLC. Founded in 2000, Osmotica Pharmaceutical Corp. operates in the Biotechnology and Pharmaceutical industries, with headquarters in the United States. The company recently received a $100.00M post-IPO debt investment on 07 October 2021 from Athyrium Capital Management. With a strong focus on addressing the global patient population's needs and a successful track record in commercializing pharmaceutical products, Osmotica Pharmaceutical Corp. presents an attractive investment opportunity for venture capitalists in the biotechnology and pharmaceutical sectors. For more company information, visit their websites: www.Osmotica.com, www.VerticalPharma.com, and www.TrigenLab.com.

Funding Stage	Amount	Investors	Date
Post-IPO Debt	••••••	1	07 Oct 2021
Post-IPO Equity	••••••	-	07 Oct 2021
Post-IPO Equity	••••••	-	08 Jan 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Post-IPO Debt

••••••

07 Oct 2021

Post-IPO Equity

••••••

07 Oct 2021

Post-IPO Equity

••••••

08 Jan 2020

FAQ About Osmotica Pharmaceutical Corp.

Osmotica Pharmaceutical is a fully-integrated pharmaceutical company with demonstrated expertise in developing commercially successful products. As one of the world's leading osmotic drug delivery companies, we leverage our significant resources in R&D and proprietary drug delivery technology to add...

Osmotica Pharmaceutical Corp. was founded in 2000.

Osmotica Pharmaceutical Corp. is headquartered in Bridgewater, United States.

Osmotica Pharmaceutical Corp. operates in the following industries: Biotechnology, Pharmaceutical.

Osmotica Pharmaceutical Corp. has approximately 114 employees.

Osmotica Pharmaceutical Corp. has completed 3 funding rounds, raising a total of $169.50M. The latest funding stage is Post Ipo Debt.

Top alternatives and competitors to Osmotica Pharmaceutical Corp. include AustarPharma, LLC, Piedmont Pharmaceuticals, Bostal Drug Delivery, Spectrix Therapeutics, Slayback Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Osmotica Pharmaceutical Corp. and AustarPharma, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Osmotica Pharmaceutical Corp.

General Information

Track Osmotica Pharmaceutical Corp.

Discover More

About Osmotica Pharmaceutical Corp.

Funding Rounds & Investors (3)

Osmotica Pharmaceutical Corp. Alternatives & Competitors

FAQ About Osmotica Pharmaceutical Corp.

Don't just browse. Track.